Hepatic effects of halothane, isoflurane or sevoflurane anaesthesia in dogs

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 50, Issue 10, 2003, Pages 530-533

  Topal, A ^a   Gul N ^a   Ilcol Y ^a   Gorgul O S ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ETHER DERIVATIVE; GAMMA GLUTAMYLTRANSFERASE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; LACTATE DEHYDROGENASE; SEVOFLURANE;

ANESTHESIA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYMOLOGY; FEMALE; LIVER; LIVER FUNCTION TEST; MALE; PHYSIOLOGY;

ALKALINE PHOSPHATASE; ANESTHESIA; ANESTHETICS, INHALATION; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DOGS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HALOTHANE; ISOFLURANE; L-LACTATE DEHYDROGENASE; LIVER; LIVER FUNCTION TESTS; MALE; METHYL ETHERS;

EID: 3042850645     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2004.00589.x     Document Type: Article

References (35)

1. Bernard, J. M., P. F. Wouters, M. F. Doursout, B. Florence, J. E. Chelly, and R. G. Merin, 1990: Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology 72, 659-662.
2. Canpolat, I., S. Bulut, H. Özer, H. Bostancioǧlu, and Z. Karakilçik, 1992: Köpeklerde halothane veya isoflurane ile anestezinin karaciǧer ve bazi kan parametreleri üzerine etkileri. F. Ü. Saǧlik. Bil. Dergisi. 6, 53-65.
3. Center, S. A., 1989: Textbook of Veterinary Internal Medicine. Saunders Company, London.
4. Colin, E. B., 1986: Halothane and the liver: the problem revisited and mode dosolete. BMJ 292, 1691-1692.
5. Dales, M., 1976: Unexplained hepatitis following halothane. BMJ 2, 1588-1589.
6. Darling, J. R., P. C. Sharpe, E. K. Stiby, J. A. McAteer, G. P. R. Archbold, and K. R. Milligan, 2000: Serum mitochondrial aspartate transaminase activity after isoflurane or halothane anaesthesia. Br. J. Anaesth. 85, 195-198.
7. Delclaux, S. R., C. Jayr, D. F. Luo, N. Saidi, M. Meignan, and F. Duvaldestin, 1998: Halothane and isoflurane decrease alveolar epithelial fluid clearance in rats. Anesthesiology 88, 751-760.
8. Farrell, G. C., L. Frost, M. Tapner, J. Field, M. Weltman, and J. Mahoney, 1996: Halothane-induced liver injury in guinea pigs: importance of cytochrome P450 enzyme activity and hepatic blood flow. J. Gastroenterol. Hepatol. 11, 594-601.
9. Frink, E. J., S. E. Morgan, A. Coatzee, and B. R. Brown, 1990: Effects of sevoflurane, isoflurane and halothane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology 73, A 558.
10. Frink, E. J., H. Ghantous, T. P. Malan, S. Morgan, J. Fernando, and J. Gandolfi, 1992: Plasma inorganic fluoride with sevoflurane anaesthesia: correlation with indices of hepatic and renal function. Anesth. Analg. 74, 231-235.
11. Gaunt, P. S., D. J. Meuten, and M. E. Pecquet-Goad, 1984: Hepatic necrosis associated with use of halothane in a dog. J. Am. Vet. Med. Assoc. 184, 478-480.
12. Gopinath, C., R. S. Jones, and E. J. H. Ford, 1970: The effect of repeated administration of halothane on the liver of the horse. J. Pathol. 102, 107-114.
13. Helmy, S. A. K., and R. J. Al-Attiyah, 2000: The effect of halothane and isoflurane on plasma cytokine levels. Anaesthesia 55, 899-910.
14. Jones, M., and J. G. Kenna, 1992: National database on halothane hepatitis. Lancet 339, 1107.
15. Kanaya, N., M. Nakayama, S. Fujita, and A. Namiki, 1995: Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance. Br. J. Anaesth. 74, 164-167.
16. Kenna, J. G., J. Neuberger, G. M. Vergani, A. P. Mowat, and R. Williams, 1987: Halothane hepatitis in children. BMJ 294, 1209-1210.
17. Kharasch, E. D., and D. Hankins, 1996: Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet 347, 1367-1371.
18. McEven, M. M., R. D. Gleed, J. W. Ludder, T. Stokol, F. Del Piero, and H. N. Erb, 2000: Hepatic effects of halothane and isoflurane anaesthesia in goats. J. Am. Vet. Med. Assoc. 217, 1697-1700.
19. Masaki, E., 1999: Inhibitory effects of nitric oxide on the metabolism of halogenated volatile anesthetics by cytocrome P-450. J. Anesth. 13, 83-89.
20. Neuberger, J., and R. Williams, 1984: Halothane anaesthesia and liver damage. BMJ 289, 1136-1139.
21. Nishiyama, T., T. Yokoyama, and K. Hanaoka, 1998a: Liver function after sevoflurane or isoflurane anaesthesia in neurosurgical patients. Can. J. Anaesth. 45, 753-756.
22. Nishiyama, T., T. Yokoyama, and K. Hanaoka, 1998b: Liver and renal function after repeated sevoflurane or isoflurane anaesthesia. Can. J. Anaesth. 45, 789-793.
23. Nishiyama, T., T. Yokoyama, and K. Hanaoka, 1999: Effects of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver function. Acta Anaesthesiol. Scand. 43, 347-351.
24. O'brien, T. D., M. R. Raffe, and V. S. Cox, 1986: Hepatic necrosis following halothane anaesthesia in goats. J. Am. Vet. Med. Assoc. 189, 1591-1595.
25. Obata, R., H. Bito, M. Ohmura, G. Moriwaki, Y. Ikeuchi, T. Katoh, and S. Sato, 2000. The effects of prolonged low-flow sevoflurane anaesthesia on renal and hepatic function. Anesth. Analg. 91, 1262-1268.
26. Ray, D. C., and G. B. Drummond, 1991: Halothane hepatitis. BMJ 67, 84-99.
27. Rodes, J., and M. Bruguera, 2001: The uses of error: iatrogenic hepatitis. Lancet 357, 791.
28. Sato, N., K. Fuji, and O. Yuge, 1994: In vivo and in vitro sevoflurane-induced lipid peroxidation in guinea pig liver microsomes. Pharmacol. Toxicol. 75, 366-370.
29. Schmidh, C. C., S. W. Suttner, S. M. Piper, D. Nagel, and J. Boldt, 1999: Comparison of the effects of desflurane and isoflurane anaesthesia on hepatocelluler function assessed by alpha glutathione S-transferase. Anaesthesia 54, 1204-1219.
30. Shichinohe, Y., Y. Masuda, H. Takahashi, M. Kotaki, T. Omote, M. Shichinohe, and A. Namiki, 1992: A case of postoperative hepatic injury after sevoflurane anesthesia. Masui 41, 1802-1805.
31. Sinclair, M., 1980. The liver and halothane again. BMJ 280, 1617-1618.
32. Smith, G. C., J. G. Kenna, D. J. Harrison, D. Tew, and C. R. Wolf, 1993: Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. Lancet 342, 963-964.
33. Suttner, S. W., C. C. Schmidt, J. Boldt, I. Hüttner, B. Kumle, and S. N. Piper, 2000: Low-flow desflurane and sevoflurane anesthesia minimally effect hepatic integrity and function in elderly patients. Anesth. Analg. 91, 206-212.
34. Van Dyke, R. A., 1982: Hepatic centrolobular necrosis in rats after exposure to halothane, enflurane or isoflurane. Anesth. Analg. 61, 812-819.
35. Williams, B. D., N. White, P. L. Amlot, J. Slaney, and P. A. Toseland, 1977: Circulating immune complexes after repeated halothane anaesthesia. BMJ 2, 159-162.